Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity

内科学 内分泌学 医学 肥胖 受体 瘦素 小鼠苗条素受体 脂肪组织 激素 糖尿病 激素受体 2型糖尿病 胰岛素
作者
Ania M. Jastreboff,Lee M. Kaplan,Melanie Jane Davies,John P.H. Wilding,Nadia N. Ahmad,Megan H. Murray,Yu Du,Nune Makarova,Kathryn Giblin,Nanette Cathrin Schloot,Yan Wang
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:395 (18): 1781-1793 被引量:12
标识
DOI:10.1056/nejmoa2604169
摘要

BACKGROUND: Retatrutide is a triple-receptor agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1, and glucagon receptors. METHODS: In this phase 3, randomized, double-blind trial, we assigned adults with obesity without diabetes to receive a once-weekly subcutaneous injection of retatrutide (at a dose of 4 mg, 9 mg, or 12 mg) or placebo for 80 weeks. Primary outcomes (evaluated in the 9-mg and 12-mg groups each vs. placebo) were the percent change in body weight and the change in the WOMAC pain score (ranging from 1 to 10, with higher scores indicating worse pain) in the subgroup of 574 participants with knee osteoarthritis and the change in the apnea-hypopnea index in the 243 participants with obstructive sleep apnea. For weight-related end points, intercurrent events were handled by a treatment-regimen estimand (intention-to-treat [ITT]). For end points in participants with knee osteoarthritis or obstructive sleep apnea, a hybrid-treatment estimand was applied, with a hypothetical strategy for intercurrent events suggesting treatment failure; ITT results are also reported. RESULTS: A total of 2339 participants underwent randomization. The mean percent change in body weight in the retatrutide groups was -17.6% (4-mg dose), -23.7% (9-mg dose), and -25.0% (12-mg dose) versus -3.9% in the placebo group (differences, -19.8 and -21.0 percentage points, respectively; P<0.001 for both comparisons). Among the participants with knee osteoarthritis, the corresponding changes in the pain score in the retatrutide groups for the hybrid estimand were -3.2, -3.5, and -3.6 versus -1.9 with placebo (differences, -1.6 and -1.8 points; both P<0.001); the corresponding changes for the ITT estimand were -3.4, -3.9, and -4.1 versus -2.5 with placebo (differences, -1.4 and -1.6 points; both P<0.001). Among the participants with obstructive sleep apnea, the corresponding changes in events per hour in the retatrutide groups for the hybrid-treatment estimand were -22.9, -34.3, and -31.7 versus -9.9 (differences, -24.4 and -21.9; both P<0.001); the corresponding changes for the ITT estimand were -22.8, -34.3, and -32.1 versus -9.6 (differences, -24.7 and -22.5; both P<0.001). The most common adverse events were gastrointestinal. CONCLUSIONS: In adults with obesity, retatrutide resulted in significant weight reduction, reduced pain in participants with knee osteoarthritis, and reduced apnea-hypopnea events in participants with obstructive sleep apnea. (Funded by Eli Lilly; TRIUMPH-1 ClinicalTrials.gov number, NCT05929066.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
科研通AI65的应助被江辞采纳,获得10
1秒前
abc37完成签到,获得积分10
1秒前
郑建辉发布了新的文献求助10
2秒前
2秒前
白江虎发布了新的文献求助10
2秒前
2秒前
海盗船长发布了新的文献求助10
3秒前
Amoy完成签到,获得积分10
3秒前
清脆的夜白完成签到,获得积分10
4秒前
万能图书馆的应助被panpan采纳,获得10
4秒前
禤X完成签到,获得积分10
5秒前
kfy发布了新的文献求助10
6秒前
6秒前
6秒前
7秒前
期待夏天完成签到,获得积分20
7秒前
7秒前
9秒前
开心乌冬面完成签到 ,获得积分10
10秒前
李静发布了新的文献求助10
11秒前
11秒前
疯癫科研人完成签到,获得积分10
11秒前
hu完成签到,获得积分10
11秒前
ZWX完成签到,获得积分10
12秒前
hhhxjv发布了新的文献求助10
12秒前
13秒前
13秒前
bkagyin的应助被myj采纳,获得30
13秒前
BZ233发布了新的文献求助10
13秒前
uni完成签到 ,获得积分10
14秒前
小橙子完成签到 ,获得积分10
15秒前
残酷日光完成签到,获得积分10
16秒前
香蕉觅云的应助被Selbst采纳,获得10
16秒前
朴实的薯片完成签到,获得积分20
16秒前
学不会完成签到,获得积分10
17秒前
无极微光的应助被小鱼采纳,获得20
18秒前
隐形曼青的应助被陶醉白梅采纳,获得10
18秒前
19秒前
李静完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191470
求助须知:如何正确求助?哪些是违规求助? 9578281
关于积分的说明 21858031
捐赠科研通 7790820
什么是DOI,文献DOI怎么找? 3436651
关于科研通互助平台的介绍 2560362
邀请新用户注册赠送积分活动 2483375